| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.13 | 2e-05 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.13 | 4e-05 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-05 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.23 | 5e-05 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.15 | 6e-05 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.14 | 7e-05 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.14 | 8e-05 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 9e-05 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.16 | 9e-05 |